However, the ratio between intact and injected side indicated a positive trend in CDNF-treated group compared to PBS-treated group (Supplemental Fig.
← all excerpts
Cerebral dopamine neurotrophic factor (CDNF) protects against quinolinic acid-induced toxicity in in vitro and in vivo models of Huntington's disease.
1
—
—